AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2718973 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasoconstricting nasal spray
Number of subjects: 25
Study 2718973 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 25
Study 776325 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic skin drapes
Number of subjects: 0
Study 776325 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic wound drapes
Number of subjects: 0
Study 776325 — intervention group
Group type: COMPARATOR
Intervention: Control (no plastic drapes)
Number of subjects: 0
Study 31773885 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Emergency Department Intervention (GEDI) model; nurse-led, physician-championed intervention; details on dosage and duration not specified.
Number of subjects: 0
Study 31773885 — intervention group
Group type: COMPARATOR
Intervention: Pre-GEDI, interim GEDI, and post-GEDI time periods; control group not explicitly defined but implies comparison across time periods.
Number of subjects: 0
Study 31216533 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted Lifestyle‐integrated Functional Exercise (aLiFE) programme
Number of subjects: 31
Study 28856843 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Health Questionnaire-9 items (online screening program)
Number of subjects: 230
Study 25212229 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) - high dose
Number of subjects: 50
Study 25212229 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) - medium dose
Number of subjects: 50
Study 25212229 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) - low dose
Number of subjects: 50
Study 25212229 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 22864620 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% glyceryl trinitrate (GTN) ointment
Number of subjects: 203
Study 22864620 — intervention group
Group type: COMPARATOR
Intervention: Control (no GTN ointment)
Number of subjects: 203
Study 21605381 — intervention group
Group type: EXPERIMENTAL
Intervention: On-line palliative care training program with tutorship using a Moodle Platform
Number of subjects: 169
Study 21605381 — intervention group
Group type: COMPARATOR
Intervention: Traditional education
Number of subjects: 169
Study 19451915 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone 2-6 mg per day over 2-12 weeks
Number of subjects: 143
Study 16882592 — intervention group
Group type: EXPERIMENTAL
Intervention: Balneotherapy
Number of subjects: 60
Study 16882592 — intervention group
Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 60
Study 15605131 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-administered massage and breathing techniques during latent phase of labour
Number of subjects: 40
Study 15605131 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 40
Study 11164149 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA cutoff of 3.0 ng/mL or greater
Number of subjects: 8612
Study 11164149 — intervention group
Group type: COMPARATOR
Intervention: PSA cutoff of 4.0 ng/mL or greater
Number of subjects: 8612
Study 11164149 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA range 3.0 to 3.9 ng/mL (new protocol)
Number of subjects: 8612
Study 11164149 — intervention group
Group type: COMPARATOR
Intervention: PSA range 3.0 to 3.9 ng/mL (original protocol)
Number of subjects: 8612
Study 11164149 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA levels less than 2.9 ng/mL
Number of subjects: 8612
Study 9227295 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral aminophylline
Number of subjects: 13
Study 9227295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 8188835 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation and percutaneous Kirschner wiring with cast
Number of subjects: 23
Study 8188835 — intervention group
Group type: COMPARATOR
Intervention: Manipulation and cast alone
Number of subjects: 23
Study 3115843 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1.75 g for 15 days)
Number of subjects: 49
Study 3115843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 3115843 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 hour fast
Number of subjects: 49
Study 29108888 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain intervention (nutritional guidance, exercise, cognitive training, and management of metabolic and vascular risk factors)
Number of subjects: 1260
Study 29108888 — intervention group
Group type: COMPARATOR
Intervention: Control group (general health advice)
Number of subjects: 1260
Study 29108888 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain intervention
Number of subjects: 1260
Study 29108888 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1260
Study 27470060 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable coaptive tape-based skin closure device
Number of subjects: 40
Study 27470060 — intervention group
Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 40
Study 24746000 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg three times a week for 12 months
Number of subjects: 92
Study 24746000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 24746000 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 92
Study 23328428 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified chitosan medical anti-adhesion membrane
Number of subjects: 86
Study 20123873 — intervention group
Group type: EXPERIMENTAL
Intervention: Air abrasion followed by acid etching with 37 percent phosphoric acid
Number of subjects: 45
Study 20123873 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser followed by acid etching with 37 percent phosphoric acid
Number of subjects: 45
Study 20123873 — intervention group
Group type: COMPARATOR
Intervention: 37 percent phosphoric acid
Number of subjects: 45
Study 18166408 — intervention group
Group type: EXPERIMENTAL
Intervention: Retreatment every 2 months (group A)
Number of subjects: 203
Study 18166408 — intervention group
Group type: COMPARATOR
Intervention: Retreatment every 3 months (group B)
Number of subjects: 203
Study 15588043 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium (18-microg)
Number of subjects: 20
Study 15588043 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol (50-microg)
Number of subjects: 20
Study 15588043 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium + Salmeterol (18-microg + 50-microg)
Number of subjects: 20
Study 11137723 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold applied for 5 min before injection
Number of subjects: 63
Study 11137723 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold applied for 5 min after injection
Number of subjects: 63
Study 11137723 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold applied for 5 min pre and post injection
Number of subjects: 63
Study 11137723 — intervention group
Group type: COMPARATOR
Intervention: No cold applied (control group)
Number of subjects: 63
Study 9174866 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic stent insertion
Number of subjects: 201
Study 9174866 — intervention group
Group type: COMPARATOR
Intervention: Surgical biliary bypass
Number of subjects: 201
Study 7513876 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy guided by suppression of spontaneous arrhythmias
Number of subjects: 486
Study 7513876 — intervention group
Group type: COMPARATOR
Intervention: Pharmacotherapy guided by suppression of stimulation‐inducible VT/VF
Number of subjects: 486
Study 7513876 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 486
Study 7513876 — intervention group
Group type: COMPARATOR
Intervention: Sodium channel blockers (imipramine, mexiletine, procainamide, propafenone, pirmenol, quinidine)
Number of subjects: 486
Study 3117570 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum lactic dehydrogenase (S-LDH) levels below 7.0 mukat 1(-1)
Number of subjects: 93
Study 3117570 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum lactic dehydrogenase (S-LDH) levels above 7.0 mukat 1(-1)
Number of subjects: 93
Study 30768388 — intervention group
Group type: EXPERIMENTAL
Intervention: Incredible Years parenting intervention
Number of subjects: 387
Study 30768388 — intervention group
Group type: COMPARATOR
Intervention: Control group (families with only child difficulties or less severe difficulties)
Number of subjects: 387
Study 30415553 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/d folic acid supplements
Number of subjects: 60
Study 30415553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 27562972 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (rapid intravenous infusion of up to 2 L of cold saline)
Number of subjects: 1198
Study 27562972 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1198
Study 23132511 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabumetone
Number of subjects: 60
Study 23132511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 21737482 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Assessment in Advanced Dementia scale (PAINAD)
Number of subjects: 79
Study 21737482 — intervention group
Group type: EXPERIMENTAL
Intervention: Disability Distress Assessment Tool (DisDAT)
Number of subjects: 79
Study 19552963 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone ER 3-12 mg/day
Number of subjects: 193
Study 19552963 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study 17328999 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo administration
Number of subjects: 8
Study 17328999 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg nitrazepam
Number of subjects: 8
Study 17328999 — intervention group
Group type: COMPARATOR
Intervention: Drug-free condition
Number of subjects: 8
Study 15809948 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryo/Cuff
Number of subjects: 60
Study 15809948 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (EDA)
Number of subjects: 60
Study 15809948 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 11498318 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg ephedrine
Number of subjects: 108
Study 11498318 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg ephedrine
Number of subjects: 108
Study 11498318 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg ephedrine
Number of subjects: 108
Study 8989009 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalloid prehydration (500 mL Hartmanns solution, n = 29)
Number of subjects: 85
Study 8989009 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloid prehydration (500 mL Haemaccel, n = 28)
Number of subjects: 85
Study 8989009 — intervention group
Group type: COMPARATOR
Intervention: No prehydration (n = 28)
Number of subjects: 85
Study 8381228 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 0
Study 8381228 — intervention group
Group type: COMPARATOR
Intervention: Permixon
Number of subjects: 0
Study 8381228 — intervention group
Group type: COMPARATOR
Intervention: Bazoton
Number of subjects: 0
Study 8381228 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8381228 — intervention group
Group type: COMPARATOR
Intervention: Various plant extracts (Talso, Strogen Forte, Prostagutt, Tadenan)
Number of subjects: 0
Study 3623762 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic Cefuroxime
Number of subjects: 295
Study 3623762 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime in bone cement
Number of subjects: 295
Study 31705339 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Gynophilus®) with metronidazole (500 mg twice a day)
Number of subjects: 90
Study 31705339 — intervention group
Group type: COMPARATOR
Intervention: Placebo with metronidazole (500 mg twice a day)
Number of subjects: 90
Study 31004619 — intervention group
Group type: EXPERIMENTAL
Intervention: MaiStep delivered by psychologists (IG1)
Number of subjects: 1654
Study 31004619 — intervention group
Group type: EXPERIMENTAL
Intervention: MaiStep delivered by teachers (IG2)
Number of subjects: 1654
Study 31004619 — intervention group
Group type: COMPARATOR
Intervention: Active Control Group (ACG)
Number of subjects: 1654
Study 31004619 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy subsample (N2)
Number of subjects: 1654
Study 31004619 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthreshold eating disorder sample (N3)
Number of subjects: 1654
Study 29049211 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 400mg 24 hours preoperative administration (EPEA)
Number of subjects: 206
Study 29049211 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 400mg 1 hour preoperative administration (PEA)
Number of subjects: 206
Study 29049211 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib 400mg 4 hours postoperative administration (POA)
Number of subjects: 206
Study 29049211 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of pethidine
Number of subjects: 206
Study 29049211 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events (AEs)
Number of subjects: 206
Study 25311651 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (20 mg L, 2 mg Z, 0.3 mg MZ)
Number of subjects: 63
Study 25311651 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (10 mg L, 2 mg Z, 10 mg MZ)
Number of subjects: 63
Study 25311651 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (3 mg L, 2 mg Z, 17 mg MZ)
Number of subjects: 63
Study 23758974 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Management Support (SMS) training for practice nurses
Number of subjects: 460
Study 23758974 — intervention group
Group type: COMPARATOR
Intervention: Control group (practice nurses without SMS training)
Number of subjects: 460
Study 21306828 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi Modal Distraction (MMD) Group
Number of subjects: 40
Study 21306828 — intervention group
Group type: COMPARATOR
Intervention: Standard Distraction (SD) Group
Number of subjects: 40
Study 18650802 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotigotine (4 mg/24 h to 24 mg/24 h)
Number of subjects: 130
Study 18650802 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 18650802 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin (400 mg)
Number of subjects: 130
Study 16646724 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 14652861 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple blind variance estimators for sample size recalculation
Number of subjects: 0
Study 14652861 — intervention group
Group type: EXPERIMENTAL
Intervention: Permutation test analysis with blind sample size recalculation
Number of subjects: 0
Study 10941718 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (100 micrograms of selenomethionine daily)
Number of subjects: 23
Study 10941718 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 23
Study 9403482 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral cerebellar lesions
Number of subjects: 10
Study 9403482 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 10
Study 8473421 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified swim-up sperm preparation
Number of subjects: 0
Study 8473421 — intervention group
Group type: COMPARATOR
Intervention: Percoll sperm preparation
Number of subjects: 0
Study 8473421 — intervention group
Group type: COMPARATOR
Intervention: Control group with no sperm preparation
Number of subjects: 0
Study 31752762 — intervention group
Group type: EXPERIMENTAL
Intervention: Path-oriented Psychological Self-help Intervention (P-oPSI) led by nurses for 1 month
Number of subjects: 76
Study 31752762 — intervention group
Group type: COMPARATOR
Intervention: Mental health lecture (wait list control group)
Number of subjects: 76
Study 29232308 — intervention group
Group type: EXPERIMENTAL
Intervention: Backward Walking Training (BWT)
Number of subjects: 18
Study 29232308 — intervention group
Group type: COMPARATOR
Intervention: Standing Balance Training (SBT)
Number of subjects: 18
Study 27055853 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential learning (SEQ)
Number of subjects: 53
Study 27055853 — intervention group
Group type: COMPARATOR
Intervention: Simultaneous learning (SIM)
Number of subjects: 53
Study 24749847 — intervention group
Group type: EXPERIMENTAL
Intervention: Icatibant (30 mg subcutaneously)
Number of subjects: 72
Study 23083653 — intervention group
Group type: EXPERIMENTAL
Intervention: Retropubic mid urethral sling
Number of subjects: 597
Study 23083653 — intervention group
Group type: EXPERIMENTAL
Intervention: Transobturator mid urethral sling
Number of subjects: 597
Study 20520370 — intervention group
Group type: EXPERIMENTAL
Intervention: Hygiene-based nonpharmaceutical interventions (NPIs) including hand washing, sanitizer use, and covering coughs and sneezes.
Number of subjects: 0
Study 18762955 — intervention group
Group type: EXPERIMENTAL
Intervention: Omentoplasty
Number of subjects: 943
Study 18762955 — intervention group
Group type: COMPARATOR
Intervention: No omentoplasty
Number of subjects: 943
Study 15875527 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine hydrochloride, 10 mg/d
Number of subjects: 113
Study 15875527 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexofenadine hydrochloride, 120 mg/d
Number of subjects: 113
Study 15875527 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine, 10 mg/d
Number of subjects: 113
Study 15875527 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose), twice daily
Number of subjects: 113
Study 12821423 — intervention group
Group type: EXPERIMENTAL
Intervention: OPCAB
Number of subjects: 251
Study 12821423 — intervention group
Group type: COMPARATOR
Intervention: CABG
Number of subjects: 251
Study 10451399 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula containing 0.9 mg/litre iron
Number of subjects: 493
Study 10451399 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula containing 1.2 mg/litre iron
Number of subjects: 493
Study 10451399 — intervention group
Group type: COMPARATOR
Intervention: Cows' milk as before
Number of subjects: 493
Study 9772613 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuizhi Tuyuan Powder (SZTYP) combined with nifedipine
Number of subjects: 0
Study 9772613 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (control group)
Number of subjects: 0
Study 1877559 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant (Survanta)
Number of subjects: 36
Study 1877559 — intervention group
Group type: COMPARATOR
Intervention: Control (air)
Number of subjects: 36
Study 7122662 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (0.3 mg/kg)
Number of subjects: 0
Study 7122662 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 0
Study 30518646 — intervention group
Group type: EXPERIMENTAL
Intervention: gB/MF59 vaccine
Number of subjects: 0
Study 30518646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28977167 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (GFJ)
Number of subjects: 18
Study 28977167 — intervention group
Group type: COMPARATOR
Intervention: Apple juice (CON)
Number of subjects: 18
Study 26607778 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel and carboplatin (PC)
Number of subjects: 112
Study 26607778 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin, cyclophosphamide and epirubicin (CEP)
Number of subjects: 112
Study 26607778 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant concurrent chemoradiotherapy followed by chemotherapy
Number of subjects: 112
Study 25316464 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic doxycycline
Number of subjects: 76
Study 25316464 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 76
Study 22965590 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3‐mg ranibizumab
Number of subjects: 759
Study 22965590 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5‐mg ranibizumab
Number of subjects: 759
Study 22965590 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 759
Study 22965590 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab (0.3‐mg and 0.5‐mg)
Number of subjects: 759
Study 22965590 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite outcome (photographic changes + clinically important events)
Number of subjects: 759
Study 20027352 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaferon in complex therapy
Number of subjects: 0
Study 17968162 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic colectomy (HALC)
Number of subjects: 81
Study 17968162 — intervention group
Group type: COMPARATOR
Intervention: Open colectomy (OC)
Number of subjects: 81
Study 17968162 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HALC and OC
Number of subjects: 81
Study 15494201 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedative music (30 min)
Number of subjects: 61
Study 15494201 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled rest
Number of subjects: 61
Study 15494201 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 61
Study 11479782 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic treatment
Number of subjects: 20
Study 11479782 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9749809 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational game (G)
Number of subjects: 131
Study 9749809 — intervention group
Group type: COMPARATOR
Intervention: Conventional method (CM)
Number of subjects: 131
Study 7849442 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (100 micrograms bolus followed by continuous intravenous infusion at 25 micrograms/h for 24 hours; 100 micrograms t.i.d. subcutaneously for 6 days)
Number of subjects: 60
Study 7849442 — intervention group
Group type: COMPARATOR
Intervention: Terlypressin (2 mg intravenous bolus every 4 hours for 24 hours; 2 mg every 6 hours on the 2nd day; 1 mg every 6 hours from the 3rd to 7th days)
Number of subjects: 60
Study 7849442 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 60
Study 7849442 — intervention group
Group type: COMPARATOR
Intervention: Terlypressin
Number of subjects: 60